| 英文名称 |
中文名称 |
CAS号 |
操作 |
| Dibenzazepine |
|
209984-56-5 |
详细
|
|
(E)-3-(2-(1H-四氮唑-5-基)乙烯基)-6-氟-1H-吲哚 |
1316695-35-8 |
详细
|
| Caroverine HCl |
盐酸卡罗维林 |
55750-05-5 |
详细
|
| Fevipiprant |
非维匹仑 |
872365-14-5 |
详细
|
| BI-3406 |
N-((R)-1-(3-氨基-5-(三氟甲基)苯基)乙基)-7-甲氧基-2-甲基-6-(((S)-四氢呋喃-3-基)氧基)喹唑啉-4-胺 |
2230836-55-0 |
详细
|
| A-966492 |
|
934162-61-5 |
详细
|
| Amsilarotene (TAC-101) |
4-[[3,5-二(三甲基硅烷基)苯甲酰基]氨基]苯甲酸 |
125973-56-0 |
详细
|
| Siramesine HCl |
西拉美新盐酸盐 |
224177-60-0 |
详细
|
| BD1063 2HCL |
BD1063盐酸盐 |
206996-13-6 |
详细
|
| ACTB-1003 |
N-[4-[4-氨基-6-(甲氧基甲基)-7-(4-吗啉基甲基)吡咯并[2,1-f][1,2,4]三嗪-5-基]-2-氟苯基]-N'-[2-氟-5-(三氟甲基)苯基]脲 |
939805-30-8 |
详细
|
| MRTX-1257 |
|
2206736-04-9 |
详细
|
| AT-527 |
|
1998705-64-8 |
详细
|
| Darexaban |
N-[2-羟基-6-(4-甲氧基苯甲酰氨基)苯基]-4-(4-甲基-1,4-二氮杂庚烷-1-基)苯甲酰胺 |
365462-23-3 |
详细
|
| GDC-0214 |
|
1831144-46-7 |
详细
|
| RSVA 405 |
N'-(4-(二乙基氨基)-2-羟基亚苄基)异烟酰肼 |
140405-36-3 |
详细
|
| TG4-155 |
|
1164462-05-8 |
详细
|
| CC-885 |
|
1010100-07-8 |
详细
|
| IGS-1.76 |
N-(苯并[d]噻唑-2-基)-3,3-二苯基丙酰胺 |
313480-47-6 |
详细
|
| Tetramethylcurcumin |
四甲基姜黄素 |
52328-97-9 |
详细
|
| Tyrphostin 23 |
酪氨酸磷酸化抑制剂23 |
118409-57-7 |
详细
|
| MBX4132 |
|
2286411-30-9 |
详细
|
| WAY-659694 |
N-(4-甲基-2-氧代-2H-苯并吡喃-7-基)-4-硝基苯甲酰胺 |
867301-81-3 |
详细
|
| Semaxanib(SU5416) |
|
194413-58-6 |
详细
|
| SC66 |
(2E,6E)-2,6-二(4-吡啶基亚甲基)环己酮 |
871361-88-5 |
详细
|
| Adjudin(AF-2364) |
|
252025-52-8 |
详细
|
| ML348 |
|
899713-86-1 |
详细
|
| TB5 |
|
948841-07-4 |
详细
|
| SGC-GAK-1 |
|
2226517-76-4 |
详细
|
| QNZ (EVP4593) |
N4-[2-(4-苯氧基苯基)乙基]-4,6-喹唑啉二胺 |
545380-34-5 |
详细
|
|
|
123066-64-8 |
详细
|
| Tie2 kinase inhibitor |
4-(6-甲氧基-2-萘)-2-(4-甲基亚磺酰基苯基)-5-(4-吡啶)-1H-咪唑 |
948557-43-5 |
详细
|
| SR17018 |
|
2134602-45-0 |
详细
|
| CD38 inhibitor 1 |
|
1700637-55-3 |
详细
|
| SB505124 |
|
694433-59-5 |
详细
|
| Delavirdine mesylate |
甲磺酸地拉韦啶 |
147221-93-0 |
详细
|
| GSK3β Inhibitor II |
4-[5-[[(3-碘苯基)甲基]硫基]-1,3,4-恶二唑-2-基]吡啶 |
478482-75-6 |
详细
|
| RHPS 4 methosulfate |
RHPS 4 甲基硫酸盐 |
390362-78-4 |
详细
|
| SR4370 |
|
1816294-67-3 |
详细
|
| GF109203X.HCl |
|
176504-36-2 |
详细
|
| AOH1996 |
|
2089314-64-5 |
详细
|
| SJ-172550 |
|
431979-47-4 |
详细
|
| TMC-647055 |
|
1204416-97-6 |
详细
|
| SU11274 |
N-(3-氯苯基)-N-甲基-3-[[3,5-二甲基-4-[(4-甲基哌嗪-1-基)羰基-1H-吡咯-2-基]亚甲基]-2-氧代-2,3-二氢-1H-吲哚-5-磺酰胺 |
658084-23-2 |
详细
|
| GW 6471 |
|
880635-03-0 |
详细
|
| Radiprodil |
|
496054-87-6 |
详细
|
| AZ304 |
|
942507-42-8 |
详细
|
| SB297006 |
|
58816-69-6 |
详细
|
| BIBF-0775 |
|
334951-90-5 |
详细
|
| MLS1547 |
|
315698-36-3 |
详细
|
| CP671305 |
|
445295-04-5 |
详细
|
| UAMC3203 |
|
2271358-64-4 |
详细
|
| GMB-475 |
|
2490599-18-1 |
详细
|
| JMS-17-2 |
|
1380392-05-1 |
详细
|
|
|
2086772-26-9 |
详细
|
| SB 215505 |
|
162100-15-4 |
详细
|
| H7 |
|
84477-87-2 |
详细
|
|
3-乙基-1-丙基-8-(1-(3-(三氟甲基)苄基)-1H-吡唑-4-基)-1H-嘌呤-2,6(3H,8H)-二酮 |
752222-83-6 |
详细
|
| VH-298 |
|
2097381-85-4 |
详细
|
| DPH |
5-(3-(4-氟苯基)-1-苯基-1H-吡唑-4-基)咪唑烷-2,4-二酮 |
484049-04-9 |
详细
|
| SMS1-IN-1 |
|
1807943-38-9 |
详细
|
| N6022 |
|
1208315-24-5 |
详细
|
| Ro3280 |
化合物Ro3280 |
1062243-51-9 |
详细
|
| Triapine |
2-[(3-氨基吡啶-2-基)亚甲基]氨基硫脲 |
143621-35-6 |
详细
|
| Y11 |
|
1086639-59-9 |
详细
|
| WHI-P180 |
3-[(6,7-二甲氧基-4-喹唑啉基)氨基]苯酚 |
211555-08-7 |
详细
|
| JP 1302 2HCl |
N-(4-(4-甲基哌嗪-1-基)苯基)吖啶-9-胺二盐酸盐 |
1259314-65-2 |
详细
|
| SU4312 |
3-[[4-(二甲基氨基)苯基]亚甲基]-1,3-二氢-2H-吲哚-2-酮 |
5812-07-7 |
详细
|
| MQAE |
1-(2-乙氧基-2-氧代乙基)-6-甲氧基喹啉-1-鎓溴化物 |
162558-52-3 |
详细
|
| INH6 |
N-[4-(2,4,6-三甲基苯基)-2-噻唑基]苯甲酰胺 |
1001753-24-7 |
详细
|
| IND24 |
|
1426047-44-0 |
详细
|
| DCVJ |
2-((2,3,6,7-四氢-1H,5H-吡啶并[3,2,1-ij]喹啉-9-基)亚甲基)丙二腈 |
58293-56-4 |
详细
|
| GCPII-IN-1 |
(S)-2-(3-((S)-5-氨基-1-羧基戊基)脲基)戊二酸 |
1025796-32-0 |
详细
|
| MIP-1072 |
|
949575-20-6 |
详细
|
| GSK621 |
|
1346607-05-3 |
详细
|
| PKM2-IN-1 |
|
94164-88-2 |
详细
|
| COH-SR4 |
1,3-双(3,5-二氯苯基)脲 |
73439-19-7 |
详细
|
| JP1302 |
N-(4-(4-甲基哌嗪-1-基)苯基)吖啶-9-胺 |
80259-18-3 |
详细
|
| DC260126 |
|
346692-04-4 |
详细
|
| SC-236 |
4-(5-(4-氯苯基)-3-三氟甲基)-1H-吡唑-1-基)苯磺酰胺 |
170569-86-5 |
详细
|
| AT-13387 |
(2,4-二羟基-5-异丙基苯基)(5-((4-甲基哌嗪-1-基)甲基)异吲哚啉-2-基)甲酮 |
912999-49-6 |
详细
|
| LM 22A4 |
N,N',N''-三(2-羟基乙基)-1,3,5-苯三甲酰胺 |
37988-18-4 |
详细
|
| Empesertib(BAY 1161909) |
|
1443763-60-7 |
详细
|
| hCAIX-IN-5 |
|
2451479-57-3 |
详细
|
| KRN-633 |
N-[2-氯-4-[(6,7-二甲氧基-4-喹唑啉基)氧基]苯基]-N-丙基脲 |
286370-15-8 |
详细
|
| 5-HT3 antagonist-4i |
N-(3-氯-2-甲基苯基)喹喔啉-2-甲酰胺 |
930478-88-9 |
详细
|
| Tacalcitol |
他卡西醇 |
57333-96-7 |
详细
|
| Dimethylcurcumin |
二甲基姜黄素 |
52328-98-0 |
详细
|
| FT011 |
(E)-2-(3-(3-甲氧基-4-(丙-2-炔-1-基氧基)苯基)丙烯酰胺基)苯甲酸 |
1001288-58-9 |
详细
|
| SMI-4a |
(5Z)-5-[[3-(三氟甲基)苯基]亚甲基]-2,4-噻唑烷二酮 |
438190-29-5 |
详细
|
| SW033291 |
2-(丁基亚磺酰基)-4-苯基-6-(噻吩-2-基)噻吩并[2,3-b]吡啶-3-胺 |
459147-39-8 |
详细
|
| PFK15 (PFK-015) |
1-(4-吡啶基)-3-(2-喹啉基)-2-丙烯-1-酮 |
4382-63-2 |
详细
|
| STF-62247 |
N-(3-甲基苯基)-4-(4-吡啶)-2-噻唑胺 |
315702-99-9 |
详细
|
| Lorediplon |
|
917393-39-6 |
详细
|
| NS 1619 |
1-(2-羟基-5-(三氟甲基)苯基)-5-(三氟甲基)-1H-苯并[D]咪唑-2(3H)-酮 |
153587-01-0 |
详细
|
| Piflufolastat |
|
1423758-00-2 |
详细
|
| PFI-90 |
N'-(吡啶-2-基)吡啶-2-甲酰肼 |
53995-62-3 |
详细
|
| HG106 |
|
928712-10-1 |
详细
|
| NVP-2 |
|
1263373-43-8 |
详细
|
| OSMI-1 |
|
1681056-61-0 |
详细
|
| 5-LOX-IN-1 |
(2-吗啉-4-苯基噻唑-5-基)(苯基)甲酮 |
55040-82-9 |
详细
|